ArticleCellular and molecular life sciences : CMLS2026

PARK2 Inhibits the progression of colorectal cancer via ubiquitinating MARCKSL1 to inhibit the c-Myc pathway.

Jian Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.